Cargando…

Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease

Despite extensive research and seven approved drugs, the complex interplay of genes, proteins, and pathways in Alzheimer’s disease remains a challenge. This implies the intricacies of the mechanism for Alzheimer’s disease, which involves the interaction of hundreds of genes, proteins, and pathways....

Descripción completa

Detalles Bibliográficos
Autores principales:	Passero, Marina, Zhai, Tianhua, Huang, Zuyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341567/ https://www.ncbi.nlm.nih.gov/pubmed/37444065 http://dx.doi.org/10.3390/ijerph20136217

Ejemplares similares

Blocking cholesterol storage to treat Alzheimer’s disease
por: Chang, Ta Yuan, et al.
Publicado: (2021)

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
por: Cummings, Jeffrey L., et al.
Publicado: (2023)

Discovery of MurA Inhibitors as Novel Antimicrobials through an Integrated Computational and Experimental Approach
por: Zhang, Fangyuan, et al.
Publicado: (2022)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

Sigma-2 Receptor—A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis
por: Yang, Kai, et al.
Publicado: (2020)

Synergistic Effect of Chlorogenic Acid and Caffeic Acid with Fosfomycin on Growth Inhibition of a Resistant Listeria monocytogenes Strain
por: Zhang, Fangyuan, et al.
Publicado: (2020)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Cholesterol and Alzheimer's
por: Sedwick, Caitlin
Publicado: (2007)

Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates
por: Vargas, D. M., et al.
Publicado: (2018)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
por: Hannaoui, Samia, et al.
Publicado: (2014)

Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017)

PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
por: Papotti, Bianca, et al.
Publicado: (2022)

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
por: Kim, Jong Youl, et al.
Publicado: (2020)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana, Justina P, et al.
Publicado: (2018)

Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
por: Chen, Win Ning, et al.
Publicado: (2022)

Cholesterol prevents Alzheimer's
por: LeBrasseur, Nicole
Publicado: (2004)

Cholesterol hastens Alzheimer's
por: LeBrasseur, Nicole
Publicado: (2004)

Roles of Cholesterol and Lipids in the Etiopathogenesis of Alzheimer's Disease
por: Rojo, Leonel, et al.
Publicado: (2006)

Links between copper and cholesterol in Alzheimer's disease
por: Hung, Ya Hui, et al.
Publicado: (2013)

The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
por: Wang, Pan, et al.
Publicado: (2020)

Microglia and Cholesterol Handling: Implications for Alzheimer’s Disease
por: Muñoz Herrera, Oscar M., et al.
Publicado: (2022)

Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
por: Varma, Vijay R., et al.
Publicado: (2021)

The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease
por: Ling, Tan Sook, et al.
Publicado: (2021)

The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking
por: Montesinos, Jorge, et al.
Publicado: (2020)

Investigating the eukaryotic host-like SLiMs in microbial mimitopes and their potential as novel drug targets for treating autoimmune diseases
por: Garg, Anjali, et al.
Publicado: (2022)

Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning
por: Yuan, Xin, et al.
Publicado: (2023)

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
por: Reid, Patrick C, et al.
Publicado: (2007)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

Reactive Astrocytes as Drug Target in Alzheimer's Disease
por: Assefa, Brhane Teklebrhan, et al.
Publicado: (2018)

TRPV1: A Potential Drug Target for Treating Various Diseases
por: Brito, Rafael, et al.
Publicado: (2014)

Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
por: Guzmán-Martinez, Leonardo, et al.
Publicado: (2013)

An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery
por: Donaldson, Olivia, et al.
Publicado: (2013)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer’s Disease and Brain Ischemia
por: Prikhodko, Veronika, et al.
Publicado: (2020)

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
por: Calsolaro, Valeria, et al.
Publicado: (2019)

Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
por: Adorni, Maria Pia, et al.
Publicado: (2019)

Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease
por: Calderón, Juan F., et al.
Publicado: (2018)

Mitochondrial Cholesterol in Alzheimer's Disease and Niemann–Pick Type C Disease
por: Torres, Sandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jn4t9usmuc2i9o6q26i4hnppti